Ludewig Stefan, Jarbouh Rami, Ardelt Michael, Mothes Henning, Rauchfuß Falk, Fahrner René, Zanow Jürgen, Settmacher Utz
Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Gastroenterol Res Pract. 2017;2017:2795176. doi: 10.1155/2017/2795176. Epub 2017 May 28.
Intestinal fatty acid-binding protein (I-FABP) has been shown to be of high diagnostic value in patients with acute mesenteric ischemia. Whether these results can be reproduced in critically ill patients on the ICU was to be investigated.
I-FABP was measured in serum and urine of 43 critically ill patients in ICU when mesenteric ischemia was suspected. Bowel ischemia was confirmed in 21 patients (group 1). 22 patients who survived at least seven days without confirmation of ischemia were assigned to group 2. I-FABP levels were compared between the groups, and interval from the event that has triggered ischemia to I-FABP measurement was recorded.
For the identification of patients with mesenteric ischemia, sensitivity, specificity, and area under the curve (AUC) for serum and urine I-FABP were 33.3%, 95.5%, and 0.565 and 81.3%, 70.0%, and 0.694, respectively. I-FABP measurements performed within 12 to 48 h after the event that triggered ischemia showed a sensitivity, specificity, and AUC for serum and urine of 75%, 100%, and 0.853 and 100%, 73.3%, and 0.856, respectively.
In ICU patients, one single I-FABP measurement at the time of clinical suspicion failed to reliably detect or exclude mesenteric ischemia. A higher diagnostic value of I-FABP was only confirmed in the early stages of mesenteric ischemia. I-FABP may be used most appropriately in perioperative monitoring.
肠脂肪酸结合蛋白(I-FABP)已被证明在急性肠系膜缺血患者中具有较高的诊断价值。本研究旨在探讨这些结果能否在重症监护病房(ICU)的危重症患者中得到重现。
对43例ICU中疑似肠系膜缺血的危重症患者的血清和尿液进行I-FABP检测。21例患者确诊为肠缺血(第1组)。22例存活至少7天且未确诊缺血的患者被分配到第2组。比较两组之间的I-FABP水平,并记录从引发缺血事件到进行I-FABP检测的时间间隔。
对于肠系膜缺血患者的识别,血清和尿液I-FABP的敏感性、特异性和曲线下面积(AUC)分别为33.3%、95.5%和0.565,以及81.3%、70.0%和0.694。在引发缺血事件后12至48小时内进行的I-FABP检测显示,血清和尿液的敏感性、特异性和AUC分别为75%、100%和0.853,以及100%、73.3%和0.856。
在ICU患者中,临床怀疑时单次I-FABP检测未能可靠地检测或排除肠系膜缺血。仅在肠系膜缺血的早期阶段证实I-FABP具有较高的诊断价值。I-FABP可能最适用于围手术期监测。